Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma

NCT01804218 is registered in ClinicalTrials.gov with Invion, Inc. as lead sponsor.

NCT NCT01804218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Lead sponsor
Invion, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
Not reported
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mild persistent asthma, uncomplicated